If any big pharma saw tremendous value in NWBO or saw them as threat, partnerships would be inked by now or around UK approval. If we do not see any announcement in parallel with UK approval then there likely is no interest from big pharma. That will be clear.
You can gaslight as much as you want. It’s all a can kicking exercise and you have been adept at that over the years. First, the publication will change the narrative, then TLD then MIA and the list goes on! I am sorry but no one is buying this. Why isn’t SIO
buying tens of millions of shares on a daily/weekly basis in the open market if they see the value like you do and that these catalysts were imminent? They ought to be protecting the investment they made at .40 by providing support at these levels and take the opportunity to average down.
Market Data 
Markets 
AI
